NIH awards more contracts to develop new testing technologies
The National Institutes of Health鈥檚 Rapid Acceleration of Diagnostics initiative yesterday $98.4 million in contracts to scale up and manufacture new COVID-19 testing technologies.
鈥淭he current round of awards support five technologies that can be delivered to the point of care and a powerful laboratory test,鈥 said Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering. 鈥淭he technologies include an antigen test that provides results in 15 minutes, a viral RNA test deployed in mobile vans that can travel to COVID hotspots and tests that require only saliva, nasal swabs or blood from a finger prick.鈥
Related News Articles
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium鈥
Headline
The Food and Drug Administration July 10 approved Moderna鈥檚 Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that鈥
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational鈥
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention鈥
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England鈥
Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥